FDA.reportPublic FDA data

ORPHENADRINE CITRATE

Substance profile for UNII X0A40N8I4S, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ORPHENADRINE CITRATE
Structure render from PubChem CID 83823

Substance Identity#

UNII
X0A40N8I4S
Preferred term
ORPHENADRINE CITRATE
Registry number
4682-36-4
EC number
225-137-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C18H23NO.C6H8O7
Chemical structure for ORPHENADRINE CITRATE
Structure render from PubChem CID 83823

Chemical And Database Identifiers#

SMILES
OC(=O)CC(O)(CC(O)=O)C(O)=O.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2C
RxCUI
7716
PubChem
83823
NCIt
C47641
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound83823https://pubchem.ncbi.nlm.nih.gov/compound/83823
RxNorm7716https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=7716
NCI ThesaurusC47641https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47641
FDA Substance Registration SystemX0A40N8I4Shttps://precision.fda.gov/uniisearch/srs/unii/X0A40N8I4S
European Community number225-137-5https://commonchemistry.cas.org/results?q=225-137-5

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate Extended-Release Tablets1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate Extended-Release Tablets Gavis Pharmaceuticals, LLC.1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate Extended-Release Tablets Gavis Pharmaceuticals, LLC.2
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate Extended-Release Tablets Gavis Pharmaceuticals, LLC.2
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate Extended-Release Tablets1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate Extended-release Tablets, 100 mg1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate Extended-release Tablets, 100 mg2
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4Se506b8dc-36b3-44f2-9fd6-316233efeb8b1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate Extended-Release Tablets1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate, Aspirin and Caffeine Tablets1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate Extended-Release Tablets1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SOrphenadrine Citrate Extended-Release Tablets1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE (ORPHENADRINE CITRATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3221
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]16
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET [EON LABS, INC.]14
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [GAVIS PHARMACEUTICALS, LLC]12
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]11
orphenadrine citrateACTIVE INGREDIENTX0A40N8I4SNORGESIC (ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE) TABLET, MULTILAYER NORGESIC FORTE (ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE) TABLET, MULTILAYER [3M PHARMACEUTICALS]4
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE INJECTION [WATSON LABORATORIES, INC.]4
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS, INC.]3
orphenadrine citrateACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]2
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET [CARILION MATERIALS MANAGEMENT]2
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]2
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [CLINICAL SOLUTIONS WHOLESALE]2
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [DIRECT RX]2
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]2
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [PROFICIENT RX LP]2
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [UNIT DOSE SERVICES]2
orphenadrine citrateACTIVE INGREDIENTX0A40N8I4SNORFLEX (ORPHENADRINE CITRATE) TABLET, EXTENDED RELEASE NORFLEX (ORPHENADRINE CITRATE) INJECTION [3M PHARMACEUTICALS]1
Orphenadrine CitrateACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE INJECTION [AKORN, INC.]1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET [PREFERRED PHARMACEUTICALS, INC.]1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS LLC]1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING]1
ORPHENADRINE CITRATEACTIVE INGREDIENTX0A40N8I4SORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [AVKARE, INC.]1